nodes	percent_of_prediction	percent_of_DWPC	metapath
Fingolimod—SPHK1—VEGFA-VEGFR2 Pathway—WASF1—conduct disorder	0.0326	0.0353	CbGpPWpGaD
Fingolimod—CYP4F12—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0317	0.0343	CbGpPWpGaD
Fingolimod—SPHK1—Signaling by VEGF—WASF1—conduct disorder	0.0308	0.0333	CbGpPWpGaD
Fingolimod—S1PR1—GPCRs, Other—DRD4—conduct disorder	0.0293	0.0317	CbGpPWpGaD
Fingolimod—CYP4F2—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0273	0.0296	CbGpPWpGaD
Fingolimod—S1PR4—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0223	0.0241	CbGpPWpGaD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0215	0.0232	CbGpPWpGaD
Fingolimod—S1PR3—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0215	0.0232	CbGpPWpGaD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0195	0.0211	CbGpPWpGaD
Fingolimod—S1PR1—GPCRs, Other—HTR2A—conduct disorder	0.0191	0.0207	CbGpPWpGaD
Fingolimod—S1PR5—brain—conduct disorder	0.0182	0.238	CbGeAlD
Fingolimod—S1PR4—GPCR ligand binding—CGA—conduct disorder	0.017	0.0184	CbGpPWpGaD
Fingolimod—CYP4F12—Biological oxidations—COMT—conduct disorder	0.0169	0.0183	CbGpPWpGaD
Fingolimod—CYP4F12—Biological oxidations—MAOA—conduct disorder	0.0168	0.0182	CbGpPWpGaD
Fingolimod—CYP4F12—Metapathway biotransformation—COMT—conduct disorder	0.0167	0.0181	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—CGA—conduct disorder	0.0163	0.0177	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—CGA—conduct disorder	0.0163	0.0177	CbGpPWpGaD
Fingolimod—S1PR4—G alpha (i) signalling events—DRD4—conduct disorder	0.0157	0.017	CbGpPWpGaD
Fingolimod—S1PR3—brain—conduct disorder	0.0151	0.198	CbGeAlD
Fingolimod—S1PR5—G alpha (i) signalling events—DRD4—conduct disorder	0.0151	0.0164	CbGpPWpGaD
Fingolimod—S1PR3—G alpha (i) signalling events—DRD4—conduct disorder	0.0151	0.0164	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—CGA—conduct disorder	0.0148	0.0161	CbGpPWpGaD
Fingolimod—CYP4F2—Biological oxidations—COMT—conduct disorder	0.0146	0.0158	CbGpPWpGaD
Fingolimod—CYP4F2—Biological oxidations—MAOA—conduct disorder	0.0145	0.0157	CbGpPWpGaD
Fingolimod—CYP4F2—Metapathway biotransformation—COMT—conduct disorder	0.0144	0.0156	CbGpPWpGaD
Fingolimod—S1PR1—G alpha (i) signalling events—DRD4—conduct disorder	0.0137	0.0149	CbGpPWpGaD
Fingolimod—S1PR1—brain—conduct disorder	0.0133	0.175	CbGeAlD
Fingolimod—SPHK1—brain—conduct disorder	0.0132	0.173	CbGeAlD
Fingolimod—CYP4F12—brain—conduct disorder	0.0127	0.166	CbGeAlD
Fingolimod—S1PR4—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.0125	0.0135	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.0124	0.0135	CbGpPWpGaD
Fingolimod—S1PR3—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.012	0.013	CbGpPWpGaD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.012	0.013	CbGpPWpGaD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.0109	0.0118	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.0107	0.0116	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—CGA—conduct disorder	0.00959	0.0104	CbGpPWpGaD
Fingolimod—S1PR4—GPCR ligand binding—DRD4—conduct disorder	0.00951	0.0103	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of proteins—CGA—conduct disorder	0.00924	0.01	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—CGA—conduct disorder	0.00924	0.01	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—CGA—conduct disorder	0.00924	0.01	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—DRD4—conduct disorder	0.00915	0.00991	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—DRD4—conduct disorder	0.00915	0.00991	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—CGA—conduct disorder	0.00871	0.00943	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—CGA—conduct disorder	0.00839	0.00908	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—CGA—conduct disorder	0.00839	0.00908	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—CGA—conduct disorder	0.00839	0.00908	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—DRD4—conduct disorder	0.00831	0.009	CbGpPWpGaD
Fingolimod—S1PR4—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00815	0.00882	CbGpPWpGaD
Fingolimod—S1PR3—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00784	0.00849	CbGpPWpGaD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00784	0.00849	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—CGA—conduct disorder	0.00762	0.00825	CbGpPWpGaD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00712	0.00771	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—CGA—conduct disorder	0.00642	0.00695	CbGpPWpGaD
Fingolimod—S1PR4—GPCR ligand binding—HTR2A—conduct disorder	0.0062	0.00672	CbGpPWpGaD
Fingolimod—CYP2D6—Melatonin metabolism and effects—MAOA—conduct disorder	0.00604	0.00654	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—HTR2A—conduct disorder	0.00597	0.00647	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—HTR2A—conduct disorder	0.00597	0.00647	CbGpPWpGaD
Fingolimod—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.00582	0.00631	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—CGA—conduct disorder	0.00554	0.006	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—HTR2A—conduct disorder	0.00542	0.00587	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—DRD4—conduct disorder	0.00537	0.00582	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—DRD4—conduct disorder	0.00517	0.0056	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—DRD4—conduct disorder	0.00517	0.0056	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CGA—conduct disorder	0.00515	0.00557	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CGA—conduct disorder	0.00495	0.00536	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CGA—conduct disorder	0.00495	0.00536	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—DRD4—conduct disorder	0.00488	0.00528	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—CGA—conduct disorder	0.00476	0.00516	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—DRD4—conduct disorder	0.0047	0.00509	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—DRD4—conduct disorder	0.0047	0.00509	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—DRD4—conduct disorder	0.0047	0.00508	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CGA—conduct disorder	0.0045	0.00487	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—DRD4—conduct disorder	0.00426	0.00462	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—WASF1—conduct disorder	0.00412	0.00447	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CGA—conduct disorder	0.00398	0.00431	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—WASF1—conduct disorder	0.00397	0.0043	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—WASF1—conduct disorder	0.00397	0.0043	CbGpPWpGaD
Fingolimod—CYP2E1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00386	0.00418	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—WASF1—conduct disorder	0.00361	0.0039	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—HTR2A—conduct disorder	0.00351	0.0038	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—HTR2A—conduct disorder	0.00337	0.00365	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—HTR2A—conduct disorder	0.00337	0.00365	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—WASF1—conduct disorder	0.00319	0.00345	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—HTR2A—conduct disorder	0.00318	0.00345	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—HTR2A—conduct disorder	0.00306	0.00332	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—HTR2A—conduct disorder	0.00306	0.00332	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—HTR2A—conduct disorder	0.00306	0.00332	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—COMT—conduct disorder	0.0029	0.00314	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—DRD4—conduct disorder	0.00288	0.00312	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—MAOA—conduct disorder	0.00288	0.00312	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—HTR2A—conduct disorder	0.00278	0.00301	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—DRD4—conduct disorder	0.00277	0.003	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—DRD4—conduct disorder	0.00277	0.003	CbGpPWpGaD
Fingolimod—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00274	0.00296	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—DRD4—conduct disorder	0.00252	0.00273	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—COMT—conduct disorder	0.0025	0.00271	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—MAOA—conduct disorder	0.00248	0.00269	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00241	0.00261	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—DRD4—conduct disorder	0.00223	0.00241	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—COMT—conduct disorder	0.00215	0.00233	CbGpPWpGaD
Fingolimod—CYP2E1—brain—conduct disorder	0.00214	0.028	CbGeAlD
Fingolimod—SPHK1—Metabolism—MAOA—conduct disorder	0.00213	0.00231	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00207	0.00224	CbGpPWpGaD
Fingolimod—CYP2E1—Biological oxidations—COMT—conduct disorder	0.00206	0.00223	CbGpPWpGaD
Fingolimod—CYP2E1—Biological oxidations—MAOA—conduct disorder	0.00205	0.00222	CbGpPWpGaD
Fingolimod—CYP2E1—Metapathway biotransformation—COMT—conduct disorder	0.00203	0.0022	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—HTR2A—conduct disorder	0.00188	0.00204	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—HTR2A—conduct disorder	0.00181	0.00196	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—HTR2A—conduct disorder	0.00181	0.00196	CbGpPWpGaD
Fingolimod—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00179	0.00194	CbGpPWpGaD
Fingolimod—CYP2D6—brain—conduct disorder	0.00169	0.0222	CbGeAlD
Fingolimod—S1PR1—Signaling Pathways—HTR2A—conduct disorder	0.00164	0.00178	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—COMT—conduct disorder	0.00146	0.00159	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—HTR2A—conduct disorder	0.00145	0.00158	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—MAOA—conduct disorder	0.00145	0.00157	CbGpPWpGaD
Fingolimod—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	0.00144	0.00156	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—EP300—conduct disorder	0.00124	0.00135	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—EP300—conduct disorder	0.00107	0.00116	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—EP300—conduct disorder	0.000996	0.00108	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—EP300—conduct disorder	0.000959	0.00104	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—EP300—conduct disorder	0.000959	0.00104	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—COMT—conduct disorder	0.000957	0.00104	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.00095	0.00103	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.000944	0.00102	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—EP300—conduct disorder	0.000922	0.000998	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—EP300—conduct disorder	0.000871	0.000943	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CGA—conduct disorder	0.000782	0.000846	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—EP300—conduct disorder	0.000771	0.000834	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CGA—conduct disorder	0.000555	0.000601	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CGA—conduct disorder	0.000363	0.000393	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—COMT—conduct disorder	0.000353	0.000382	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—MAOA—conduct disorder	0.00035	0.000379	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—COMT—conduct disorder	0.00025	0.000271	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—MAOA—conduct disorder	0.000249	0.000269	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—COMT—conduct disorder	0.000164	0.000177	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—MAOA—conduct disorder	0.000163	0.000176	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—EP300—conduct disorder	0.000151	0.000164	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—EP300—conduct disorder	0.000107	0.000116	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—EP300—conduct disorder	7.02e-05	7.6e-05	CbGpPWpGaD
